Skip to content
10-Q

Quarterly Report

Anacor Pharmaceuticals, Inc.

0001104659-16-119730

← back to feed
Filed
May 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 2, 2016 45.37M sh
Capex Q1 2016 · Mar 31, 2016 $70K
Capex Q1 2016 · Mar 31, 2015 $95K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $24.97M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $53.68M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $22.06M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $15.99M
Stockholders Equity Q1 2016 · Mar 31, 2016 $44.58M
Stockholders Equity Q1 2016 · Dec 31, 2015 $52.29M
Current Liabilities Q1 2016 · Mar 31, 2016 $25.01M
Current Liabilities Q1 2016 · Dec 31, 2015 $29.51M
Current Assets Q1 2016 · Mar 31, 2016 $157.3M
Current Assets Q1 2016 · Dec 31, 2015 $170.1M
Total Assets Q1 2016 · Mar 31, 2016 $164M
Total Assets Q1 2016 · Dec 31, 2015 $176.1M
Sga Expense Q1 2016 · Mar 31, 2016 $12.17M
Sga Expense Q1 2016 · Mar 31, 2015 $8.15M
Rd Expense Q1 2016 · Mar 31, 2016 $19.36M
Rd Expense Q1 2016 · Mar 31, 2015 $18.16M
Operating Income Q1 2016 · Mar 31, 2016 −$14.92M
Operating Income Q1 2016 · Mar 31, 2015 −$11.8M
Cost Of Revenue Q1 2016 · Mar 31, 2016 $929K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $754K
Revenue Q1 2016 · Mar 31, 2016 $17.54M
Revenue Q1 2016 · Mar 31, 2015 $15.26M